LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 144

Search options

  1. Article ; Online: Detection and Prediction of Macrophage Activation Syndrome in Still’s Disease

    Clément Javaux / Thomas El-Jammal / Pierre-Antoine Neau / Nicolas Fournier / Mathieu Gerfaud-Valentin / Laurent Perard / Marine Fouillet-Desjonqueres / Julie Le Scanff / Emmanuelle Vignot / Stéphane Durupt / Arnaud Hot / Alexandre Belot / Isabelle Durieu / Thomas Henry / Pascal Sève / Yvan Jamilloux

    Journal of Clinical Medicine, Vol 11, Iss 206, p

    2022  Volume 206

    Abstract: Distinguishing between macrophage activation syndrome (MAS) and a simple flare of Still’s disease ...

    Abstract Distinguishing between macrophage activation syndrome (MAS) and a simple flare of Still’s disease (SD) may be challenging. We sought to clarify the clinical features and outcome of MAS in SD and to explore predictive factors of MAS development. Demographic and clinical data, treatments, and outcomes were recorded in a cohort of 206 SD patients. SD patients with and without MAS were compared. To explore predictive factors for the development of MAS, patients were compared at the time of SD diagnosis. Twenty (9.7%) patients experienced MAS, which was inaugural in 12 cases. Patients with MAS were more likely to have hepatomegaly (OR, 3.71; 95% CI, 1.14–11.2; p = 0.03) and neurological symptoms (OR, 4.43; 95% CI, 1.08–15.3; p = 0.04) than patients without MAS. Cytopenias, abnormal liver tests, and coagulation disorders were significantly more frequent in patients with MAS; lactate dehydrogenase and serum ferritin levels were significantly higher. An optimized threshold of 3500 μg/L for serum ferritin yielded a sensitivity (Se) of 85% and a negative predictive value (NPV) of 97% for identifying patients with/without MAS. Survival analysis showed that a high ferritin level at the time of SD diagnosis was predictive of MAS development ( p < 0.001). Specific factors, including neurological symptoms, cytopenias, elevated LDH, and coagulopathy, may contribute to the early detection of MAS. Extreme hyperferritinemia at the onset of SD is a prognostic factor for the development of MAS.
    Keywords adult-onset Still’s disease ; macrophage activation syndrome ; systemic-onset juvenile idiopathic arthritis ; ferritin ; autoinflammatory disease ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2022-12-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: De 2023 à 2024 : consolider nos acquis, garder le cap de l’innovation et du progrès.

    Vignot, Stéphane / Pourquier, Philippe / l'Allemain, Gilles / Bay, Jacques-Olivier

    Bulletin du cancer

    2024  Volume 111, Issue 1, Page(s) 1–2

    Title translation From 2023 to 2024: Consolidate our achievements, stay on course for innovation and progress.
    Language French
    Publishing date 2024-01-18
    Publishing country France
    Document type Editorial
    ZDB-ID 213270-9
    ISSN 1769-6917 ; 0007-4551
    ISSN (online) 1769-6917
    ISSN 0007-4551
    DOI 10.1016/j.bulcan.2023.12.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Actualités, quand tu nous tiens….

    Bay, Jacques-Olivier / l'Allemain, Gilles / Pourquier, Philippe / Vignot, Stéphane

    Bulletin du cancer

    2023  Volume 111, Issue 2, Page(s) 127–128

    Title translation News, when you hold us….
    Language French
    Publishing date 2023-12-09
    Publishing country France
    Document type Editorial
    ZDB-ID 213270-9
    ISSN 1769-6917 ; 0007-4551
    ISSN (online) 1769-6917
    ISSN 0007-4551
    DOI 10.1016/j.bulcan.2024.01.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Abiratérone : bénéfice en survie globale et questions subsidiaires.

    Vignot, Stéphane

    Bulletin du cancer

    2015  Volume 102, Issue 6, Page(s) 487–488

    Title translation Abiraterone: Overall survival benefit and subsidiary issues.
    MeSH term(s) Androstenes/therapeutic use ; Antineoplastic Agents, Hormonal/therapeutic use ; Humans ; Male ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/pathology
    Chemical Substances Androstenes ; Antineoplastic Agents, Hormonal ; abiraterone (G819A456D0)
    Language French
    Publishing date 2015-06
    Publishing country France
    Document type Letter
    ZDB-ID 213270-9
    ISSN 1769-6917 ; 0007-4551
    ISSN (online) 1769-6917
    ISSN 0007-4551
    DOI 10.1016/j.bulcan.2015.04.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Chimiothérapie adjuvante des cancers bronchiques de stade I chez les sujets âgés. Quand une étude qui se veut positive peut s'avérer contre-productive.

    Vignot, Stéphane

    Bulletin du cancer

    2015  Volume 102, Issue 5, Page(s) 401–402

    Title translation Adjuvant chemotherapy for stage I lung cancer in the elderly.
    MeSH term(s) Aged ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Non-Small-Cell Lung/radiotherapy ; Chemotherapy, Adjuvant/adverse effects ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Lung Neoplasms/radiotherapy ; Postoperative Care
    Language French
    Publishing date 2015-05
    Publishing country France
    Document type Letter
    ZDB-ID 213270-9
    ISSN 1769-6917 ; 0007-4551
    ISSN (online) 1769-6917
    ISSN 0007-4551
    DOI 10.1016/j.bulcan.2015.04.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Immune recovery uveitis in Whipple's disease: an unusual ocular presentation.

    Lequain, Hippolyte / Abramowicz, Stéphane / Seiller, Julien / Abukhashbah, Amro / Burillon, Carole / Vignot, Emmanuelle / Brunet, Olivier / Sève, Pascal

    Journal of ophthalmic inflammation and infection

    2024  Volume 14, Issue 1, Page(s) 10

    Abstract: Purpose: To describe an unusual case of Whipple's disease (WD) complicated by uveitis, and subsequent paradoxical worsening after effective antibiotic treatment targeting Tropheryma whipplei (TW).: Methods: Case report.: Results: A 53-year-old ... ...

    Abstract Purpose: To describe an unusual case of Whipple's disease (WD) complicated by uveitis, and subsequent paradoxical worsening after effective antibiotic treatment targeting Tropheryma whipplei (TW).
    Methods: Case report.
    Results: A 53-year-old male presented with bilateral knee arthritis, weight loss, chronic low-grade fever, and cognitive disorders. He was under treatment with tumor necrosis factor α inhibitors (TNFi) for seronegative spondyloarthritis. Given this unusual clinical presentation, further investigations were performed and revealed blood, saliva, stool, synovial fluid and cerebrospinal fluid positivity for TW, confirming the diagnosis of systemic WD. Ophthalmologic examination revealed bilateral posterior uveitis and an aqueous humor sample confirmed the presence of intraocular TW. TNFi were stopped, and the patient was subsequently treated with adequate antibiotics (ceftriaxone, followed by doxycycline and hydroxychloroquine), and subconjunctival corticosteroid injections. After a transient improvement of the ocular symptoms, he presented a recurrence of posterior segment inflammation, leading to repeated PCR testing for TW which were negative. Therefore, paradoxical worsening of the inflammation in the context of immune recovery uveitis (IRU) was thought to be the culprit. The patient was treated with systemic corticosteroid therapy, allowing for rapid improvement of the ocular findings.
    Conclusions: This case underlines the possibility of IRU complicating WD. Ophthalmologists, rheumatologists, and internists should be aware of this rare complication, particularly in the context of previous immunosuppressive therapy.
    Language English
    Publishing date 2024-02-13
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2592309-2
    ISSN 1869-5760
    ISSN 1869-5760
    DOI 10.1186/s12348-024-00390-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Nouvelles modalités de prescription des autorisations temporaires d’utilisation nominatives (ATUn) : une étape clé dans l’accès à l’innovation.

    Vignot, Stéphane / Chapel, Elodie

    Bulletin du cancer

    2019  Volume 106, Issue 11, Page(s) 943–945

    Title translation New prescription procedures for authorisations for temporary use: A key step for access to innovation.
    MeSH term(s) Antineoplastic Agents/therapeutic use ; Antineoplastic Agents, Immunological/therapeutic use ; Clinical Trials as Topic ; Diffusion of Innovation ; Europe ; Hematologic Agents/therapeutic use ; Humans ; Investigational New Drug Application ; Therapies, Investigational
    Chemical Substances Antineoplastic Agents ; Antineoplastic Agents, Immunological ; Hematologic Agents
    Language French
    Publishing date 2019-09-25
    Publishing country France
    Document type Editorial
    ZDB-ID 213270-9
    ISSN 1769-6917 ; 0007-4551
    ISSN (online) 1769-6917
    ISSN 0007-4551
    DOI 10.1016/j.bulcan.2019.07.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Nouvelles modalités de prescription des ATU nominatives : un dispositif à la mesure des besoins en infectiologie.

    Vignot, S / Blaise, T / Martin, M

    Medecine et maladies infectieuses

    2019  Volume 50, Issue 4, Page(s) 386–387

    Title translation New prescription modalities for nominative premarket access: Tailored for infectiology.
    MeSH term(s) Compassionate Use Trials/legislation & jurisprudence ; Compassionate Use Trials/statistics & numerical data ; Drug Approval ; Drug Prescriptions ; France ; Humans ; Infectious Disease Medicine ; Marketing
    Language French
    Publishing date 2019-11-14
    Publishing country France
    Document type Letter
    ZDB-ID 423536-8
    ISSN 1769-6690 ; 0399-077X ; 1166-8237
    ISSN (online) 1769-6690
    ISSN 0399-077X ; 1166-8237
    DOI 10.1016/j.medmal.2019.10.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: New modalities of prescription of ATUns: Evolutions and revolution.

    Vignot, S / Plaine, G / Chapel, E

    Revue neurologique

    2019  Volume 176, Issue 4, Page(s) 290–292

    MeSH term(s) Clinical Trials as Topic/legislation & jurisprudence ; Clinical Trials as Topic/standards ; Drug Approval/legislation & jurisprudence ; Drug Approval/methods ; Drug Approval/organization & administration ; Drug Prescriptions/standards ; Drugs, Investigational/classification ; Drugs, Investigational/standards ; Drugs, Investigational/therapeutic use ; France ; Government Agencies/legislation & jurisprudence ; Government Agencies/organization & administration ; Government Agencies/standards ; Guideline Adherence ; Humans ; Legislation, Drug ; Marketing of Health Services/legislation & jurisprudence ; Marketing of Health Services/organization & administration ; Marketing of Health Services/standards ; Practice Patterns, Physicians'/standards ; Practice Patterns, Physicians'/trends ; Reference Standards ; Time Factors
    Chemical Substances Drugs, Investigational
    Language English
    Publishing date 2019-10-11
    Publishing country France
    Document type Letter
    ZDB-ID 4593-7
    ISSN 2213-0004 ; 0035-3787
    ISSN (online) 2213-0004
    ISSN 0035-3787
    DOI 10.1016/j.neurol.2019.07.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Chimiothérapie à haute dose pour le traitement des tumeurs : le début de la fin ?

    Bay, Jacques-Olivier / Vignot, Stéphane

    Bulletin du cancer

    2017  Volume 104, Issue 4, Page(s) 299–300

    Title translation High-dose chemotherapy for tumor treatment: The beginning of the end?
    Language French
    Publishing date 2017-04
    Publishing country France
    Document type Editorial
    ZDB-ID 213270-9
    ISSN 1769-6917 ; 0007-4551
    ISSN (online) 1769-6917
    ISSN 0007-4551
    DOI 10.1016/j.bulcan.2017.03.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top